Different indications depending on the underlying disease
Conditions
Interventions
Group 1: Test group: receives intensified information using VR glasses. Here, patients learn more about the MRI, the rooms and the device in a video. They also receive a short training session on the
this is a questionnaire to record anxiety or discomfort and takes about 3-4 minutes.
They then receive the standard information for the MRI from a doctor.
After the information, the STAI test is fil
this takes about 1-2 minutes.
Group 2: In the control group, the procedure is the same as in the test group, only without the additional information provided by the VR glasses.
Sponsors
Universitätsklinik für Radiologie und Nuklearmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Adult patients referred for routine Gd-EOB-DTPA-enhanced liver MRI. 2. Willingness to participate in the study and sign the informed consent. Indication for diagnostic liver MRI (initial diagnosis or follow-up)
Exclusion criteria
Exclusion criteria: 1. Known travel sickness. 2. History of epilepsy. 3. Uncorrected hearing or visual impairment that interferes with the use of the VR headset. 4. Severe cognitive impairment or reading disability that interferes with understanding or independently completing the STAI-State Anxiety questionnaire.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To investigate the hypothesis that virtual patient preparation (VRPP) in addition to standard patient preparation (SPP+VRPP) reduces patients' anxiety before liver MRI compared to SPP alone. 2. To investigate the hypothesis that SPP+VRPP increases the proportion of MRI without respiratory-induced motion artifacts in the arterial phase. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the impact of SPP+VRPP on the frequency of transient severe respiratory movements (TSM) in Gd-EOB-DTPA-enhanced liver MRI. 2. To evaluate the intra-individual change in patients' anxiety level in SPP vs. SPP+VRPP. 3. To evaluate the impact of SPP+VRPP on respiratory movement scores in dynamic phase imaging of Gd-EOB-DTPA-enhanced liver MRI. 4. To evaluate the impact of SPP+VRPP on patient satisfaction with pre-scan preparation. 5. To evaluate the impact of SPP+VRPP on patient overall satisfaction with the MRI experience. 6. To evaluate patient acceptance of VRPP. | — |
Countries
Germany
Contacts
Public ContactMaximilian Thormann
Universitätsklinik für Radiologie und Nuklearmedizin
Outcome results
None listed